News

Collaboration to identify alterations in cancer-related tumour genes.

Pioneer in droplet-based genetic analysis IP committed to expanding its foundational patent portfolio to advance novel liquid biopsy applications.

Acquisition will expand Abcam’s capabilities in multiplex analysis.

Pre-clinical studies in mice reveal ways to reduce cancer risk with modified treatment.

Study shows mutation in NGLY1 gene is linked to a genetic disorder with severe consequences.

The largest genome-wide study of the malaria parasite finds that the drug resistance occurs because of a key mutation happening on top of 'background' mutations which make the parasite more likely to develop drug resistance later.

Acquisition enables immediate presence in USA, a key market for bloodstream infection diagnosis and other applications.

New statistical method for RNA-seq analysis identifies, corrects for hidden structure between cells.

Revenues expected to be ahead of consensus by approximately 7% driven by an increased global demand for expanded product, service and IP offering.

BioInformatics LLC has recognized Bio-Rad with two prestigious Life Science Industry Awards for “Best Protein Expression & Analysis Products” and “Best Workflow Solutions — Genomics.”